Cite
HARVARD Citation
Renna, S. et al. (2018). A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. Digestive and liver disease. 50 (12), pp. 1292-1298. [Online].